News

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted 16 to 1 that available data support the safety and

Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology

Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide (CGRP) receptor

Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide (CGRP) receptor

The Board of Directors of American Express Company (NYSE: AXP) approved the repurchase of up to 120 million common shares, in accordance with the company’s capital plans that are, from time to

Chevron Corporation (NYSE: CVX) announced today the second retail event in the Chevron Exchange Q&A Series, a virtual fireside chat with President of Chevron New Energies (CNE), Jeff Gustavson, on

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that available data is adequate

Walmart Inc. (NYSE: WMT) announced today that John David Rainey, executive vice president and chief financial officer of Walmart Inc., will participate in a discussion at the Raymond James

At its annual investor meeting today, Chevron Corporation (NYSE: CVX) reported on its progress to leverage its strengths to safely deliver lower carbon energy to a growing world.

“Chevron intends

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Angela Hwang, Chief Commercial Officer, President, Global Biopharmaceutical

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the company’s Biologics License Application (BLA) for elranatamab, an

NIKE, Inc. (NYSE: NKE) plans to release its third quarter fiscal 2023 financial results on Tuesday, March 21, 2023, at approximately 1:15 p.m. PT, following the close of regular stock market

On April 4, 2023, Exxon Mobil Corporation will host a virtual Low Carbon Solutions spotlight to provide an update on the business.

Darren Woods, Chairman and Chief Executive Officer, Kathy

Walmart Inc. (NYSE: WMT):

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230220005308/en/

Fourth-quarter highlights:

• 
  Walmart

The Board of Directors of Walmart Inc. (NYSE: WMT) approved an annual cash dividend for fiscal year 2024 of $2.28 per share, an increase of approximately 2 percent from the $2.24 per share paid for

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for its respiratory syncytial virus (RSV)

Chevron Corporation (NYSE: CVX) and the Fab Foundation today announced the first recipients of an all-new fellowship program that supports STEM educators across the world. The Chevron Fab STEM

Pfizer (NYSE: PFE) announced today positive results from the Phase 3 TALAPRO-2 study of TALZENNA^® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI^®

Pfizer Inc. (NYSE: PFE) today announced publication of results in The Lancet Neurology from the Phase 3 pivotal clinical trial of zavegepant, an investigational calcitonin gene-related peptide

Walmart Inc. (NYSE: WMT) today announced it will hold a live conference call with the Investment Community at 7 a.m. CST Tuesday, Feb. 21, 2023, to discuss the company’s fourth quarter earnings

Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved its supplemental New Drug Application (sNDA) for CIBINQO^® (abrocitinib), expanding

NIKE, Inc. (NYSE: NKE) announced today that its Board of Directors has declared a quarterly cash dividend of $0.340 per share on the Company’s outstanding Class A and Class B Common Stock payable

Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Andy Schmeltz, SVP Commercial Strategy & Innovation, and Navin Katyal, U.S. Commercial &amp

Embark on a brand-new adventure with Disney Mickey Mouse’s triumphant return to video games – and this time he’s bringing a few friends! Today, Disney, in collaboration with developer Dlala

Chevron Corporation (NYSE: CVX), one of the world’s leading energy companies, will hold its annual investor day on Tuesday, February 28, 2023, at 8:30 a.m. ET (5:30 a.m. PT).

The meeting will